Gene expression of the insulin-like growth factors and their receptors in human neuroblastoma cell lines by Martin, Donna M. et al.
Molecular Brain Research, 15 (1992) 241-246 241 
© 1992 Elsevier Science Publishers B.V. All rights reserved 0169-328x/92/$05.00 
BRESM 70478 
Gene expression of the insulin-like growth factors and their receptors 
in human neuroblastoma cell lines 
D.M.  Martin a D. Y e e  c, R.O.  Carlson b and E.L. Fe ldman a 
a Department of Neurology and the Neuroscience Program, o The Mental Health Research Institute, University of Michigan, Ann Arbor, MI 48109 
(USA) and c Department of Medicine, Division of Oncology, University of Texas Health Science Center, San Antonio, TX 78284 (USA) 
(Accepted 5 May 1992) 
Key words: Insulin-like growth factor I; Insulin-like growth factor II; Type I IGF receptor; Type II IGF receptor; Neuroblastoma; mRNA 
Insulin-like growth factors (IGF) I and II are polypeptides with both growth-promoting and insulin-like metabolic effects. The developmentally 
specific expression of IGF I and II in the nervous system implies a role for these growth factors in neuronal growth and differentiation. In the 
present study, we analyzed IGF and IGF receptor mRNA transcripts from two related human neuroblastoma cell lines, SH-SY5Y and SK-N-SH. 
These cell lines provide a good in vitro model of neuronal development. Northern analysis of total RNA from each cell line revealed three IGF 
II mRNA transcripts (6.0, 4.8, and 1.8 kb), and one mRNA transcript each for the type I (11.0 kb) and type II (9.4 kb) IGF receptors. The size 
distribution of these multiple transcripts is similar to that found during normal human fetal development. These results establish both cell lines 
as good in vitro models for investigating the mechanisms which underly IGF gene expression during nervous system development. 
INTRODUCTION 
Insulin-like growth factors 1 and II ( IGF I and IGF 
II) belong to a family of polypeptides with growth 
promoting and insulin-like metabolic activity 10,33. Gene 
expression of IGF I and II is differentially regulated 
during development 8. IGF mRNAs are present in a 
wide variety of size classes, depending on the develop- 
mental stage and tissue source of the transcripts. In 
human fetal brain, the primary IGF I m R N A  species 
are 4.4 and 7.5 kb 31. In adult human brain, expression 
of IGF I m R N A  is negligible or absent 8'33, however, a 
7.0-7.5 kb IGF I m R N A  is present in adult rat brain 9. 
Transcription of the IGF II gene is initiated at one of 
four promotor sites, leading to mRNAs with similar 
coding but different 5' untranslated regions 13. A 6.0 kb 
IGF II m R N A  is abundantly expressed in fetal tissues 
with lesser expression in the adult, where a 4.8 kb 
m R N A  likely represents the major adult IGF II tran- 
script 5,6,~1,33. 
As an initial approach toward understanding the 
regulation of developmentally specific IGF m R N A  
transcripts in the nervous system, we characterized the 
different IGF m R N A  transcripts in two human neurob- 
lastoma cell lines, SH-SY5Y and its parent line, SK-N- 
SH. These cell lines were chosen as neuronal models of 
IGF  gene regulation and function for two reasons. 
First, both cell lines undergo phenotypic changes from 
mitogenically active to differentiated neurons, thereby 
providing in vitro models of normal neuronal develop- 
ment 23'24. Secondly, these phenotypic changes can be 
affected by IGFs t2'26'27'28. We therefore speculated that 
mitogenically active SH-SY5Y and SK-N-SH cells 
would have the same IGF and 1GF receptor transcripts 
as fetal neuronal tissue. 
In the current study, we have characterized all IGF  
and IGF receptor m R N A  transcripts present in ac- 
tively dividing SH-SY5Y and SK-N-SH cells. We report 
that the distribution of these transcript sizes in mito- 
genic cells is similar to that found in the developing 
nervous system. Our results in mitogenic neurons can 
serve as a basis for future comparisons between the 
IGF and IGF receptor m R N A  transcripts present in 
dividing and differentiated neuronal phenotypes. 
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MATERIALS AND METHODS 
Materials 
Dulbecco's modified Eagle's medium (DMEM) and fetal bovine 
serum (FBS) were purchased from Grand Island Biological Co. 
(Grand Island, NY). Bovine calf serum (CS) was obtained from 
Hyclone Labs (Logan, UT). Tissue culture supplies were obtained 
from Costar (Cambridge, MA) and Corning Glass Works (Corning, 
NY). All molecular biology grade reagents were from Sigma (St. 
l~uis, MO). Restriction endonucleases were purchased from 
Bethesda Research Laboratories (Gaithersburg, MD). All other 
chemicals were of reagent grade from Baker Chemical Co. (Phillips- 
burg, N J) or Fisher Scientific (Fairhaven, NJ). 
Cell cuhure 
Human SH-SY5Y and SK-N-SH cells were kindly provided by 
Dr. Stephen Fisher, University of Michigan Medical Center. Ceils 
were maintained in plastic tissue culture flasks in DMEM supple- 
mented with 10% CS for SH-SY5Y and 10% FBS for SK-N-SH. 
Cells were maintained at 37°C in a humidified atmosphere of 10% 
CO2. 
eDNA probes 
Dr. Peter S. Rotwein (Washington University School of Medicine, 
St. Louis, MO) provided the human IGF IA cDNA 3°. An 818-base 
pair (bp) sequence of the IGF IA cDNA encoding exons 1, 2, 3 and 5 
was obtained by digestion of pBlueScript KS (Stratagene, La Jolla, 
CA) with EcoRI. Dr. Graeme I. Bell (Howard Hughes Institute, 
Chicago, IL) supplied the cDNA for human IGF 1I 1. Digestion of 
pGEM4 (Promega, Madison, WI) with Pstl yielded an 854 bp region 
of IGF II cDNA encoding exons 7, 8, and part of 9 (bases 1-854). 
This cDNA was used in Northern analysis and RNase protection 
experiments. The type I IGF receptor cDNA 36 was a gift of Dr. Axel 
UIIrich (Max Planck Institute, Martinsreid, Germany). A 1247 bp 
insert (bases 1490-2737) encoding the type ! IGF receptor a and b 
chains was obtained by digestion of pGEM4 with EcoRI and Hindlll. 
Dr. William S. Sly (St. Louis University Medical Center, St. Louis, 
MO) provided the type II IGF receptor cDNA 2°. The complete 9.1 
kb type 1I IGF receptor eDNA was obtained by digestion of pGEM2 
with Sal I. All cDNAs were labelled with [32p]dCTP by random 
priming (Amersham, UK) for use in hybridization reactions. 
Northern analysis 
Northern analysis was performed as previously described l~>. 
Briefly, total cellular RNA was isolated from SH-SY5Y and SK-N-SH 
cells using guanidinium thiocyanate-phenol extraction 3. RNA sam- 
ples (20/xg) and 5 gg 0.24-9.5 kb RNA ladder (Bethesda Research 
Laboratories) were electrophoresed in denaturing gels containing 1% 
agarose, 2.2 M formaldehyde, 0.02 M MOPS (3-[N-morpholino] 
propane-sulfonic acid), 1 mM EDTA, and 5 mM sodium acetate. 
Nytran membranes (Schleicher and Schuell, Keene, NH) were hy- 
bridized with high specific activity (2-90x107 cpm//zg) cDNA 
probes for 12-16 h at 42°C. Membranes were exposed to autoradio- 
graphic film (Eastman Kodak Co., NY) in the presence of intensify- 
ing screens at - 70°C for 1-7 days. 
RNase protection assay 
RNase protection was performed as previously described 1~. RNA 
samples (10-50 ~zg) were hybridized overnight at 50°C with 5 x 104 
cpm IGF I1 riboprobe, then digested with 40 /zg/ml RNase A 
(Sigma). Samples were extracted with phenol, precipitated and resus- 
pended in 5 /zt of 80% formamide loading buffer, then elec- 
trophoresed on 6% polyacrylamide, 8 M urea sequencing gels. Gels 
were then dried and exposed to autoradiographic film using an 
intensifying screen at -70°C for 1-3 days. 
RESULTS 
IGF gene expression 
Using Northern analysis of total RNA isolated from 
SH-SY5Y and SK-N-SH cell lines, we found that an 
854 bp IGF II cDNA hybridized with 1.8, 4.8 and 6.0 
kb RNA transcripts from both cell lines (Fig. 1A,B). By 














Fig. 1. Northern analysis of IGF II in cultured human neuroblastoma cells. A: Northern blot of 20/xg total RNA from SK-N-SH and SH-SY5Y 
neuroblastoma cells. Three RNA transcripts were detected: 6.0, 4.8, and 1.8 kb. Radiograph exposed 5 days. B: photograph of ethidium 
bromide-stained gel corresponding to the membrane used in A, showing 28S (5.0 kb) and 18S (1.8 kb) rRNA bands. C: IGF II RNase protection 
assay in cultured SK-N-SH and SH-SY5Y neuroblastoma cells. An 854 bp IGF 1I cDNA obtained from human liver was used as the template for 
riboprobe synthesis. RNA from cultured human retinal pigment epithelial cells did not protect this probe, whereas RNA from both SK-N-SH 
and SH-SY5Y cells protected a 580 bp fragment. Radiograph exposed 48 h. 
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Fig. 2. Northern analysis of IGF I in cultured human neuroblastoma 
cells. A: Northern blot of 20 tzg total RNA from SK-N-SH and 
SH-SY5Y neuroblastoma cells. No RNA transcripts were detected in 
either neuroblastoma cell line, whereas the expected RNA transcript 
sizes were seen in rat liver total RNA. Radiograph exposed 3 days. 
B: photograph of ethidium bromide-stained gel corresponding to the 
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Fig. 4. Northern analysis of type II IGF receptor in cultured human 
neuroblastoma cells. A: Northern blot of 20 /zg total RNA from 
SKoN-SH and SH-SY5Y neuroblastoma cells. One 9.4 kb RNA 
transcript was detected in both neuroblastorfia cell lines. Radiograph 
exposed 5 days. B: photograph of ethidium bromide-stained gel 
corresponding to the membrane used in A, showing 28S (5.0 kb) and 
18S (1.8 kb) rRNA bands. 
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Fig. 3. Northern analysis of type I IGF receptor in cultured human 
neuroblastoma cells. A: Northern blot of 20 ~g total RNA from 
SK-N-SH and SH-S¥5Y neuroblastoma cells. One 11 kb RNA 
transcript was detected in both neuroblastoma cell lines. Radiograph 
exposed 3 days. B: photograph of ethidium bromide-stained gel 
corresponding to the membrane used in A, showing 28S (5.0 kb) and 
18S (1.8 kb) rRNA bands. 
RNase protection analysis of total RNA from both cell 
lines, we found a 580 bp fragment of the 854-bp IGF II 
probe was protected from RNase degradation. (Fig. 
1C). No specific hybridization between the 818 bp IGF 
I cDNA and total RNA from SH-SY5Y or SK-N-SH 
cells in Northern analysis experiments was detected 
(Fig. 2A,B). In the same experiments, we detected 
multiple IGF I m R N A  transcripts of 7.8, !.6-2.1, and 
0.8-1.2 kb by Northern hybridization of the 818 bp 
IGF I cDNA with rat liver total RNA (Fig. 2A,B). This 
result is consistent with previously reported IGF I 
transcript sizes in rat liver 34. 
IGF receptor gene expression 
By Northern analysis with the 1247 bp type I IGF 
receptor eDNA of total RNA from SH-SY5Y or SK-N- 
SH cells, we detected one 11 kb R N A  transcript (Fig. 
3A, B). Using Northern analysis with the 9.1 kb type II 
IGF receptor cDNA, we detected one 9.4 kb RNA 
transcript in total RNA from SH-SY5Y and SK-N-SH 
cells (Fig. 4A,B). 
DISCUSSION 
Multiple class sizes of IGF I and IGF II mRNAs are 
expressed in a tissue and time specific manner. In 
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human fetal brain, the major IGF I mRNA species are 
7.5 and 4.4 kb, while 1.6 and 2.5 kb IGF ! mRNA 
transcripts are present in the adult 3t. Transcription of 
the human IGF II gene is under the control of multiple 
promoters 13. In human fetal tissue, the P3 promoter is 
active, giving rise to abundant 6.0 kb IGF II mRNAs. 
Initiation of transcription of the P4 promoter  predomi- 
nates in the adult, producing lower total amounts of 
IGF II mRNA and a major 4.8 kb transcript 5'6. 
The developmentally specific expression of multiple 
IGF mRNA species in the nervous system implies a 
role for IGFs in neuronal growth and maturation. We 
have used two neuroblastoma cell lines, SK-N-SH and 
SH-SY5Y, as models of neuronal development. Each 
cell line can undergo active neuronal division and 
neurite outgrowth in response to I G F s  12'21'26'27'28. Simi- 
lar phenotypic changes occur in vivo in developing 
neurons, leading us to speculate that these neuroblas- 
toma cells would express fetal IGF transcripts. 
Using RNase protection assays, we detected IGF II 
mRNA in SH-SY5Y cells and, in concurrence with Yee 
and colleagues 37, in SK-N-SH cells. Northern analysis 
of both cell types revealed three IGF II mRNA tran- 
scripts: 6.0 kb, 4.8 kb and 1.8 kb. The predominant 
IGF II mRNA in both cell lines was the 6.0 kb tran- 
script, the major IGF II species in human fetal 
tissues 5'6. High levels of the 6.0 kb IGF II transcript in 
both neuroblastoma cell lines therefore mimics human 
fetal development. 
In adult human, a sharp decline in total IGF 1I 
mRNA transcript levels coincides with the increased 
presence of the 4.8 kb IGF II transcript 5'6'33. Corre- 
spondingly, we found low levels of the 4.8 kb mRNA, 
presumably under the control of the P4 promoter,  in 
actively growing SK-N-SH and SH-SY5Y cells. The 
third transcript, the 1.8 kb IGF II mRNA, was present 
in low amounts in both SK-N-SH and SH-SY5Y cells. 
While the exact significance of this transcript remains 
unclear, increasing evidence suggests it is the cleavage 
product of larger IGF lI mRNAs and functions to 
regulate total IGF II mRNA levels 3-~. 
Little is known about the potential developmental 
regulation of type I and II IGF receptor gene expres- 
sion. The type I IGF receptor is a membrane glycopro- 
tein with four subunits connected by disulfide bonds to 
give a/3-a-~-/3 tetramer. IGF I binds to the a subunits 
and stimulates autophosphorylation of the /3 subunits 
via a tyrosine-specific protein kinase is. In multiple 
tissues, IGF I cDNA hybridization reveals an 11 kb 
a n d / o r  a 7 kb transcript 36. We detected the 11 kb type 
1 IGF receptor transcript in both actively growing 
neuroblastoma cell lines, in agreement with previous 
RNase protection assays 22'37. Competitive binding and 
RNase protection assays indicate increased type I IGF 
receptor binding and mRNA levels after differentia- 
tion of SH-SY5Y cells 22, however, the potential changes 
in type I IGF receptor transcript species are unknown. 
Interestingly, when mouse 3T3-L1 fibroblasts are dif- 
ferentiated into adipocytes, there is a reduction of the 
type I IGF receptor 11 kb transcript 36. 
Unlike the type I IGF receptor, the type II IGF 
receptor is a single polypeptide with no intrinsic tyro- 
sine kinase activity. The type II IGF receptor is identi- 
cal to the mannose-6-phosphate receptor 19, which me- 
diates intracellular trafficking of lysosomal enzymes 4. 
The physiological significance of one receptor with 
distinct 2 but cooperative bindings sites for IGF II and 
mannose-6-phosphate z9 is unknown. Recent work, 
however, suggests that the type II IGF receptor may 
serve to integrate distinct growth-promoting signals 
from IGF II and mannose-6-phosphate 7 or secreted 
mannose-6-phosphate containing proteins, including 
cathepsin D t7, proliferin ~4 and transforming growth 
factor-/31 precursor 25. The presence of type II IGF 
receptor mRNA has not been previously reported in 
neuroblastoma cell lines. We detected a 9.4 kb tran- 
script in actively growing SH-SY5Y and SK-N-SH cells, 
the same size as the type II IGF receptor transcript in 
human placenta 2°. There is little information on the 
potential regulation of type II IGF receptor gene ex- 
pression with development, although competitive bind- 
ing studies with iodinated-IGFs indicate changes in 
IGF receptor subtypes during fetal maturation 32. 
We were unable to detect IGF I mRNA in either 
SK-N-SH or SH-SY5Y cells, in agreement with Yee 
and colleagues 37. We believe this increases the utility 
of these two cell lines as models of neuronal develop- 
ment. The lack of IGF I gene expression will allow us 
to examine the effects of 1GF II on neuronal growth 
and differentiation separately from IGF I. 
Examined collectively, the presence of (1) abundant 
6.0 kb IGF II mRNA with low abundance of 4.8 and 
1.8 kb IGF II mRNAs, and (2) abundant 11.0 kb type I 
and 9.4 kb type II IGF receptor mRNA in dividing 
SK-N-SH and SH-SY5Y cells supports our contention 
that these cell lines are useful for understanding the 
differential regulation of IGF and IGF receptor mRNA 
during neuronal development. As an initial step toward 
determining the role of IGFs in neuronal ontogeny, we 
have begun examining changes in IGF II gene expres- 
sion in differentiated neuroblastoma cell lines ~5. 
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